Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE technology appraisals

This article was originally published in The Gray Sheet

Executive Summary

Coronary artery stents, implantable cardioverter defibrillators, and hip prostheses will be evaluated this fall by the National Institute For Clinical Excellence, a technology appraisal program for the National Health Service in the U.K. (1"The Gray Sheet" March 22, p. 12). Manufacturers of the selected products are expected to submit existing data on clinical and cost effectiveness, the group explains Aug. 6. NICE will issue a guidance on each manufacturer's technology, indicating "whether, and under what circumstances, the technology should be routinely used in the NHS" and "whether its use should be restricted to certain categories of patients." Other areas to be examined include cervical screening, inhaler systems, hearing aids, laparoscopic surgery, and wound care

You may also be interested in...



U.K. To Begin Clinical, Cost-Effectiveness Device Assessments Next Month

Britain's National Institute of Clinical Excellence (NICE) plans to conduct on an annual basis clinical and cost-effectiveness evaluations of between 30 and 50 new and existing medical technologies, Edward Hutt, division director Quintiles Medical Technology Consultants, said March 14.

US FDA’s Unapproved Drug Initiative Nixed, But Without Agency Buy-In Demise May Be Short-Lived

Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.

E.l.f. Has A Go At Twitch Crowd, Hitching Wagon To #Loserfruit

The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.

UsernamePublicRestriction

Register

OM006550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel